Fremont County Legal THCa Rick Simpson Oil by Houston’s OilWell Cannabis: 16,590mg 7-Cannabinoid RSO Sublingual with 1,500mg Patient-Controlled THCa-to-THC Conversion, ABC13-Featured & Baylor-Connected, Bentley’s 10-Year Miracle Legacy, Farm Bill-Compliant Nationwide Shipping

Understanding Rick Simpson Oil in Fremont County, Idaho: A Complete Guide by OilWell Cannabis

If you’re reading this in Fremont County, Idaho, you’re likely looking for honest answers about cannabis oil in a state that hasn’t made them easy to find. Maybe you’re in St. Anthony or Ashton, dealing with chronic pain after years of ranch work. Perhaps you’re in Island Park or the Teton Valley, supporting a loved one through cancer treatment in Idaho Falls or Boise. You might be a veteran in Rexburg struggling with PTSD, or someone in Driggs who’s exhausted every pharmaceutical option for insomnia. Wherever you are in our corner of eastern Idaho, you’ve probably discovered that getting clear, science-based information about concentrated cannabis oil—Rick Simpson Oil, or RSO—is nearly impossible. Idaho’s restrictive cannabis laws mean no local dispensaries, no medical program beyond the most limited CBD oil, and a lot of misinformation floating around online forums.

We built OilWell Cannabis to solve exactly this problem. Based in Houston, Texas, we’ve spent six years developing what we believe is the most sophisticated, transparent, and evidence-grounded RSO formula available anywhere in the United States—and we can ship it legally to your door in Fremont County. This guide is written specifically for you: the Idaho resident who needs real information, not hype, about what RSO is, what it can and cannot do, and how to access it safely and legally in a state that makes that deliberately difficult.

The Rick Simpson Story: From Nova Scotia to Idaho’s Backcountry

Rick Simpson wasn’t a doctor. He was a power plant engineer from Amherst, Nova Scotia—a working-class guy who got hurt on the job in 1997, suffered a severe head injury from a scaffolding fall, and found himself let down by the medical system. The medications doctors prescribed made his tinnitus and post-concussion symptoms worse. When he discovered cannabis helped, his physician refused to discuss it. Sound familiar? For many in rural Idaho who’ve faced similar dismissal from physicians about cannabis as an option for pain, PTSD, or cancer support, Simpson’s story resonates deeply.

In 2003, Simpson claimed that three bumps on his arm diagnosed as basal cell carcinoma disappeared after he applied concentrated cannabis oil directly to them and covered them with bandages. He had no biopsy confirmation, no independent medical verification, and no clinical follow-up published anywhere. But that personal experience became the origin story of “Rick Simpson Oil” and sparked a global movement. After 2003, Simpson began making oil in his Maccan, Nova Scotia property and giving it away for free to cancer patients and others with conditions like chronic pain, diabetes, glaucoma, arthritis, depression, and insomnia .

His story spread through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He faced cultivation, possession, and trafficking charges. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands .

Important context for Fremont County readers: Simpson’s story is powerful because it’s personal testimony, not medical evidence. He had no medical training, never conducted a clinical trial, and his cancer cure claims have never been replicated in controlled human studies. We honor his contribution—he helped bring cannabis oil to global awareness—but we also believe Idaho residents deserve honest science, not miracle stories, when making health decisions.

What Was Traditional RSO, Exactly?

Traditional RSO was crude, unstandardized, and highly variable. Understanding what it actually was helps you evaluate what’s being sold today, including our own formula.

The Product:

• Source material: Single high-THC indica strain, no standardization between batches
• Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol—neither food-grade
• Process: Cannabis soaked in solvent, filtered, evaporated in a rice cooker at high heat
• Appearance: Nearly black, thick, tar-like oil with possible solvent-residual odor
• Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, minor cannabinoids at natural but uncontrolled ratios
• Terpene content: Essentially zero—destroyed by heat and solvent
• Testing: None. No Certificate of Analysis, no contaminant screening

The 60-Gram Protocol:
Simpson’s famous treatment course involved consuming 60 grams over approximately 90 days:

• Week 1: Half a grain of rice-sized dose (10-15mg), three times daily
• Weeks 2-5: Double dose every four days, building to 1 gram per day
• Weeks 5-12: Maintain 1 gram daily (roughly 600-900mg THC per day)
• Maintenance: 1-2 grams per month indefinitely

Critical safety concerns for Idaho:

• No controlled trials ever validated this protocol
• 600-900mg of THC daily is far beyond any studied dose—FDA-approved dronabinol is typically 2.5-20mg daily
• Real risks include severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder
• Patients with active cancer are medically complex—using unregulated oil as primary treatment can cause harm beyond the oil itself

What the Science Actually Says About Cannabis and Cancer

We know this is why many in Fremont County search for RSO. Idaho’s cancer patients often face long drives to treatment centers in Boise or Salt Lake City, and some are told there are no more options. Let’s be direct about what research shows.

Preclinical findings (interesting but not proof):

• THC and CBD can induce apoptosis (programmed cell death) and inhibit tumor growth in certain cancer cell lines and animal models
• These findings have not translated into proven human cancer cures
• No human clinical trial has demonstrated RSO or any cannabis oil cures cancer

Institutional positions:

• National Cancer Institute: Acknowledges cannabinoid anticancer research in labs and animals but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD for seizures) and synthetic THC drugs for chemo nausea are approved [1]
• Health Canada: Never approved RSO for cancer

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cancer cure claims exceed the evidence. Encouraging patients to use RSO instead of proven therapies (surgery, radiation, chemo, immunotherapy) carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern in alternative medicine.

For Fremont County cancer patients: We believe RSO education complements medical care—it does not replace it. If you’re being treated at Mountain View Hospital in Idaho Falls, Eastern Idaho Regional Medical Center, or any oncology practice, please discuss any cannabinoid use with your care team. Our goal is to give you honest information so you can make informed decisions alongside your doctors, not instead of them.

OilWell Cannabis: From Houston to Idaho’s High Desert

OilWell wasn’t born in a boardroom. It started with a dog named Bentley in a Houston apartment, thousands of miles from Fremont County’s mountains and potato fields. But Bentley’s story is why our formula exists—and why it matters for Idaho.

Bentley was paralyzed, facing euthanasia. Veterinarians said pain medications would destroy his organs. In desperation, Colin Valencia—our founder who grew up in McAllen, Texas, learning cannabis in the pre-legalization era—learned about CBD. A rescue worker asked, “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin created a CBD golden paste. Bentley got up and brought him his ball. From paralyzed to playing fetch. Dogs don’t respond to placebo. This was real.

Bentley lived ten more years, dying naturally at age twenty. During those years, Colin developed formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG for neuroprotection, THCa for PPARγ agonism
• Dementia → CBC for neurogenesis
• Glaucoma → THC for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approach using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley needed synergy. That necessity—that love for a dying companion—created the seven-cannabinoid precision formula you’re reading about now.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey using the same cannabinoid knowledge that kept Bentley alive. Our Peace Gummies formula was born during midnight experiments while fighting benzo withdrawal. He personally uses our vape form for insomnia and severe PTSD to this day.

From McAllen to the Texas Medical Center

Colin grew up in one of the most dangerous border regions in America. He saw friends killed and imprisoned. He could have gone darker paths, but chose cannabis. Later, he became a trained software engineer and did custom development for Baylor College of Medicine—one of the world’s most prestigious medical institutions. That combination—deep plant knowledge plus medical-grade technical precision—defines OilWell’s approach.

ABC13 Houston: Seven Features Over Four Years

From 2019 to 2023, Houston’s #1 news source featured us seven times, across five different reporters, covering business, law, medicine, and politics. They came to us because we tell the truth—even when it’s uncomfortable. In May 2021, when asked “Why would someone want to smoke Delta-8?” Colin’s answer was blunt: “Maybe you want to get high.” ABC13 aired it uncensored. That’s the kind of honesty that builds trust in Idaho’s skeptical market.

When Texas abruptly banned Delta-8 in October 2021, we proactively removed all products before enforcement. We warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed a major revenue loss to act ethically. That’s the kind of company you can trust when you’re making health decisions in a legally complicated state like Idaho.

Our Four Core Principles: Why We’re Different

1. Accessibility Over Gatekeeping

Idaho reality: You can’t walk into a dispensary in Ashton, St. Anthony, or even Idaho Falls because Idaho has no legal recreational or medical cannabis dispensaries. Montana’s dispensaries are across the border, but that’s a federal crime to bring back. You’re left searching online for options and hoping they’re legitimate.

Our answer: No medical card required. You must be 21 or older. That’s it. We ship directly to your door in Fremont County via USPS, FedEx, or UPS with discreet packaging. Our products are Farm Bill compliant—legal hemp-derived products containing less than 0.3% delta-9 THC at the federal level.

What this means for you:

• No qualifying conditions needed
• No doctor’s appointment required
• No driving to Montana or Washington
• No legal risk at point of purchase
• Product arrives in 2-3 business days

2. Patient-Controlled Potency: The THCa Innovation

This is the most significant legal cannabis access innovation in history, and it’s especially relevant for Idaho’s conservative, self-reliant culture.

Traditional RSO was always psychoactive—heat converted all THCa to THC. You had no choice.

Our formula contains 1,500mg of THCa in its raw, non-psychoactive form. You decide:

• Raw (no heat): All THCa stays inactive. Zero psychoactive effect. Perfect for daytime use, work, driving, or anyone who wants anti-inflammatory benefits without impairment. THCa works via COX-2 inhibition and PPARγ agonism—pathways relevant for inflammation and neuroprotection.
• Fully activated (home decarb): Heat at 260°F for 45-60 minutes converts THCa to approximately 1,315mg of delta-9 THC. Combined with existing 90mg delta-9 and 6,000mg delta-8, you get full psychoactive potency comparable to traditional illegal RSO—legally, because you activated it after legal purchase.
• Partial decarb: Transfer a portion to another container, decarb only what you need, preserve the rest raw.

For Idaho’s working families: You can use our product during the day for inflammation and pain without getting high, then activate a separate portion at night for sleep support. One purchase serves multiple needs.

3. Open-Source Formulas: Our Continuation of Rick Simpson’s Ethos

Rick Simpson gave his oil away for free and taught people to make it. We sell a professional, lab-tested product AND publish the complete recipe so anyone can make their own.

Why this matters in Fremont County:

• Economic reality: With Fremont County’s median household income around $50,000, not everyone can afford $129.99 for our sublingual oil
• Self-sufficiency: Idaho’s culture values DIY and self-reliance
• Trust: We have nothing to hide

The complete formula is published below. If you have access to cannabinoid distillates and isolates, you can source ingredients and replicate it. We’ll even help you understand the process if you contact us. This isn’t marketing—it’s our commitment to accessibility.

4. Evidence-Informed, Not Evidence-Overstating

We don’t claim our RSO cures cancer. We don’t claim CBN is a proven sleep aid. We don’t claim terpenes have proven entourage effects in humans. What we do is show you exactly what the research says—and doesn’t say—so you can decide.

Our GENERAL KNOWLEDGE section (included below) evaluates every cannabinoid and terpene using a formal evidence hierarchy:

• Human clinical trials first
• Systematic reviews and meta-analyses
• NIH institutional positions
• Preclinical literature (when human data is sparse)

We apply the same standards to our own formula that we apply to the broader field. This honesty is what builds trust in Idaho’s skeptical market.

The Science Behind Our Formula: What Each Cannabinoid Does

We include seven cannabinoids because Bentley’s conditions required synergy. Here’s what the evidence shows:

CBD (4,500mg) — The Foundation

• Best evidence: Rare epilepsies (Epidiolex FDA-approved), chemotherapy nausea, HIV/AIDS appetite
• Emerging: Anxiety (2024 meta-analysis shows significant anxiolytic signal), chronic pain (promising but heterogeneous evidence)
• Safety: Can elevate liver enzymes in some; drug interactions possible
• Why it’s here: Non-psychoactive foundation with the strongest human evidence base

CBG (3,000mg) — The Neuroprotector

• Mechanism: Interacts with CB receptors, alpha-2 adrenoceptors, 5-HT1A pathways
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity
• Reality: Commercially sold while evidence remains thin—exactly the kind of gap our evidence section addresses
• Why it’s here: Bentley’s neurodegeneration required it; preclinical neuroprotection signals are compelling

Delta-8 THC (6,000mg) — The Functional Psychoactive

• Compared to delta-9: Similar pharmacology but less potent, weaker CB1 affinity
• Evidence: Real pharmacologic activity, but human safety data is incomplete
• Public health: Adverse consequences reported; manufacturing quality concerns exist
• Why it’s here: Provides therapeutic THC effects at lower potency than delta-9; included at substantial dose for the “Asshole Peach” effect favored by veterans

THCa (1,500mg) — Your Control Valve

• Non-psychoactive: Does not produce THC’s high unless heated
• Mechanisms: COX-2 inhibition (anti-inflammatory), PPARγ agonism (neuroprotective)
• Critical for Idaho: Stays legal (non-psychoactive) until YOU decide to activate it
• Conversion: 1mg THCa → 0.877mg delta-9 THC when decarbed
• Why it’s here: Patient-controlled potency philosophy in chemical form

Delta-9 THC (90mg) — The Legal Limit

• Purpose: Minimal baseline THC for entourage effect without overwhelming psychoactivity
• Evidence: Strong for chemo nausea, appetite; concerning mental health risks at high doses
• Safety: High-concentration THC linked to psychosis, cannabis use disorder
• Why it’s here: Farm Bill compliance (under 0.3%) with enough THC for therapeutic synergy

CBN (750mg) — The Sleep Question Mark

• Reputation vs. reality: Marketed as sleep aid, but human evidence is weak
• Research: 2021 review found no clinical trials using validated sleep measures
• Dosing: At 2mL, you get 50mg CBN—the level in 2024 sleep literature
• Why it’s here: Plausible sleep support, but we don’t overstate it

CBC (750mg) — The Emerging Protector

• Pharmacology: Distinct from THC/CBD; antinociceptive, antibacterial, anti-seizure signals
• Status: Being sold commercially despite little clinical safety/efficacy data
• Why it’s here: Bentley’s dementia required neurogenesis support; preclinical neurobiological signals are strong

The Complete Formula: Transparency You Can Verify

RSO Sublingual Oil — $129.99

Cannabinoid	Amount	% of Total
CBD	4,500mg	27.1%
Delta-8 THC	6,000mg	36.2%
CBG	3,000mg	18.1%
THCa	1,500mg	9.0%
CBN	750mg	4.5%
CBC	750mg	4.5%
Delta-9 THC	90mg	0.5%
TOTAL	16,590mg	100%

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Volume: 30mL (1 fl oz)
• Potency: 553mg active cannabinoids per mL
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Doses: Approximately 40-60 per bottle (depending on serving size)

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1g cartridge, 510-thread universal battery compatible
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Note: THCa auto-decarboxylates at vaping temperature (400-450°F)

Terpene Profile: The Aromatic Dimension

Both products share the same seven-terpene profile:

1. Limonene (citrus-bright) — Antioxidant, anti-inflammatory signals
2. Myrcene — Anxiolytic preclinical data, but human proof limited
3. Caryophyllene (β-caryophyllene) — CB2 agonist, unusual terpene-cannabinoid interaction
4. Pinene (forest-fresh) — Memory/clarity hypotheses, limited human data
5. Linalool (floral, lavender) — Stress/mood preclinical, no strong human trials
6. Humulene (earthy, woody) — Anti-inflammatory rodent work, early stage
7. Terpinolene (piney, fruity) — Least characterized, mostly in vitro/animal

Bottom line: Terpenes make the experience pleasant and aromatic. Their therapeutic claims are plausible but not clinically proven. We include them for completeness and potential synergy, not as primary actives.

Idaho Legal Context: What You Need to Know

Federal Farm Bill Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight. This is the foundation of our product’s legality.

Our sublingual oil contains only 90mg delta-9 THC in the entire 30mL bottle—3mg per mL. This is well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law.

Idaho State Law Reality

Idaho is one of the most cannabis-restrictive states in America. As of 2024:

• No recreational cannabis program
• No medical cannabis program (except for the ultra-restrictive CBD oil program for epilepsy)
• No dispensaries of any kind
• Bringing cannabis across state lines (even from legal Montana) is federal interstate trafficking
• Possession of any amount of THC is a misdemeanor (first offense) or felony (subsequent)

Our product is legal in Idaho because:

1. It’s hemp-derived, not marijuana-derived
2. It contains <0.3% delta-9 THC at point of sale
3. THCa is not delta-9 THC
4. We ship with full documentation, COAs, and receipts
5. Idaho’s hemp law aligns with the Farm Bill

Your responsibility: Understand Idaho law. While our product is federally legal and Farm Bill compliant, Idaho’s legal environment around cannabis is hostile. We provide documentation for your protection, but you accept all legal risk. We cannot provide legal advice.

Shipping to Fremont County

We ship to Idaho via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days). Packages are:

• Discreet (no cannabis branding visible)
• Temperature-stable for summer heat
• Tracked with signature-required option
• Include complete COAs and receipts for documentation

For rural Fremont County addresses (Ashton, Island Park, Driggs outskirts), allow an extra day for delivery. Our PANDEM1C SEO technology ensures your order routes through the most efficient distribution center—usually Salt Lake City or Boise—for fastest rural delivery.

Important: If Idaho law changes (legislature meets annually), we will update this guide immediately. As of 2024, our products remain accessible to Idaho residents under the Farm Bill framework.

How to Use Our RSO in Fremont County: Practical Guidance

Choosing Your Format

Start with sublingual oil if:

• You need sustained relief (4-6 hours)
• You want precise dosing (graduated dropper)
• You prefer non-psychoactive daytime use
• You’re new to cannabis products

Add vape cartridge if:

• You need fast relief for breakthrough pain/panic (1-2 minute onset)
• You have acute nausea or anxiety episodes
• You’re experienced with inhalation methods
• You want portability (fishing, hiking, long drives between Idaho towns)

Idaho-Specific Dosing Scenarios

For chronic pain (fibromyalgia, arthritis, old injuries from ranch work):

• Daytime: 0.3-0.5mL raw sublingual (non-psychoactive)
• Evening: 0.5-1.0mL decarboxylated sublingual (pain + sleep support)
• Breakthrough: 2-3 vape puffs as needed
• Rationale: Multi-pathway anti-inflammatory (CBD, CBG, THCa, caryophyllene)

For sleep issues (common in high-altitude, rural stress):

• 30 minutes before bed: 1.0-2.0mL sublingual
• At 2.0mL: 50mg CBN (level in 2024 sleep literature)
• At 1.0mL: 25mg CBN (above 20mg threshold for reduced sleep disturbance)
• Rationale: CBN + CBD + delta-8 for sleep architecture

For anxiety (especially veterans, healthcare workers, isolated ranchers):

• Morning: 0.3mL raw sublingual (CBD + CBG, zero impairment)
• As needed: Vape for acute panic (fastest relief)
• Rationale: CBD anxiolytic evidence [3], CBG pharmacology [7], limonene entourage

For cancer treatment support (during chemo in Idaho Falls/Boise):

• Pre-chemo: 0.5-1.0mL sublingual 1 hour before
• Acute nausea: 2-3 vape puffs
• Post-chemo: 0.5mL every 6 hours
• Evening: 1.0-2.0mL for sleep
• Rationale: Delta-8 antiemetic [9], delta-9 chemo nausea [1][13], CBD buffering [3]

General Idaho Titration Principle

“Start low, go slow” is especially important in Idaho’s high-altitude, dry climate where dehydration and medication effects can intensify.

1. Day 1-3: 0.25mL sublingual (raw, no heat)
2. Assess for 2-3 hours: Note effects on pain, anxiety, sleep
3. Increase gradually: Add 0.1-0.2mL every 3 days until desired effect
4. Document: Keep a journal—Idaho’s variable weather, altitude, and activity levels affect response
5. Consult: If you’re being treated at Fremont County’s clinics or traveling to specialists, share your journal with providers

Decarboxylation Instructions for Idaho Homes

To activate (optional):

1. Pour desired amount into oven-safe glass container
2. Preheat oven to 260°F (verify with thermometer—Idaho’s altitude can affect oven temps)
3. Bake 45-60 minutes
4. Let cool completely
5. Store activated oil in separate container, refrigerate

Partial activation: Decarb only what you need, preserve remainder raw. This is perfect for Idaho’s budget-conscious families—one bottle serves both daytime and nighttime needs.

Safety: What Idaho Residents Must Know

Idaho-Specific Concerns

Driving in Idaho:

• THC impairment laws are strict. Idaho Code § 49-426 makes it illegal to drive with any amount of THC in your system.
• Our raw sublingual oil (THCa) will NOT cause impairment or positive drug test
• Activated/decarbed oil WILL cause impairment and WILL trigger positive drug tests
• Never drive after consuming activated product. Idaho’s DUI penalties are severe.

Workplace testing:

• Many Fremont County employers (schools, hospitals, government, agriculture) drug test
• Raw THCa product will not trigger standard THC tests
• Any activated THC (decarbed or vaped) will trigger tests
• Know your employer’s policy before using psychoactive forms

Healthcare interactions:

• Idaho’s rural healthcare system often involves multiple providers (local clinic, specialist in Idaho Falls, possibly telehealth)
• Always inform all providers about cannabinoid use due to drug interactions
• CBD can affect liver enzymes that metabolize many medications
• Bring our product’s Certificate of Analysis to appointments

Pregnancy and nursing:

• NCCIH explicitly warns against cannabis use during pregnancy
• Idaho has limited prenatal resources in rural areas
• We do not recommend our product if pregnant or nursing

Mental health:

• Idaho has higher suicide rates than national average, particularly in rural counties
• High-dose THC can worsen anxiety or trigger psychosis in vulnerable individuals
• If you have history of psychosis, schizophrenia, or severe anxiety, consult mental health provider before use

General Safety Notes

Side effects to watch for:

• Drowsiness (especially with activated THC or CBN)
• Dry mouth (common; stay hydrated—Idaho’s dry climate worsens this)
• Dizziness when standing (orthostatic hypotension)
• Appetite changes
• GI upset

Contraindications:

• Do not use with alcohol or other sedatives
• Use caution with blood thinners (CBD interaction)
• Avoid if history of cannabis use disorder
• Keep away from children and pets—Idaho’s rural homes often have both

Emergency: Fremont County’s limited emergency services mean prevention is critical. If severe reaction occurs (chest pain, severe panic, persistent vomiting), call 911 or go to Fremont County Emergency Services in St. Anthony.

Getting Started in Fremont County: Your First Order

Step 1: Verify Legal Understanding

Read Idaho Code regarding hemp products. Understand that while our product is federally legal and Farm Bill compliant, Idaho’s legal environment is hostile to cannabis. You accept responsibility. We provide documentation (COA, receipt, hemp compliance letter) for your records.

Step 2: Choose Product

Most Idaho customers start with sublingual oil because:

• Longer lasting (4-6 hours suits rural lifestyles)
• Non-psychoactive option crucial for conservative state
• Better value (16,590mg total cannabinoids)

Add vape if:

• You have breakthrough pain/anxiety
• You need fastest relief
• You’re comfortable with inhalation

Step 3: Place Order

Online: OilWellCBD.com
Phone: (832) 416-2816
Email: [email protected]

Shipping to Idaho:

• USPS Priority Mail: $9.95 (2-3 days)
• Free shipping on orders over $150
• Discreet packaging: looks like any e-commerce shipment
• Signature required recommended for security

Payment: We accept all major credit cards. Transactions appear as “OilWell CBD” on statements.

Step 4: First Use

Scenario 1: Chronic pain, daytime

• Morning: 0.3mL raw sublingual under tongue
• Hold 60 seconds, swallow
• Wait 2 hours, assess pain levels
• If needed, add 0.2mL in afternoon
• Evening: If pain persists, consider decarbing 0.5mL for nighttime use

Scenario 2: Sleep issues

• Night 1: 0.5mL sublingual (raw), 30 min before bed
• Night 3: Increase to 1.0mL if needed
• Night 5: If still inadequate, decarb 1.0mL and use that instead

Scenario 3: Cancer support during chemo

• Pre-chemo: 0.5mL sublingual (raw) 1 hour before treatment
• Post-chemo: Vape 2-3 puffs for breakthrough nausea
• Evening: 1.0-2.0mL for sleep and appetite

Step 5: Connect with Community

Idaho resources:

• Veterans: Idaho Division of Veterans Services (Boise office) – let them know you’re using alternative therapies
• Cancer support: Mountain View Hospital Cancer Center (Idaho Falls) social workers can discuss integrative approaches
• Chronic pain: Idaho Pain Management clinics (multiple locations) may be cannabinoid-friendly
• PTSD: Idaho Veterans Affairs has PTSD programs; share your cannabinoid journal with providers

Our community:

• Instagram: @oilwellcbd
• Phone: (832) 416-2816
• Email: We respond within 24 hours, even to complex questions

We cannot provide medical advice, but we can help you understand the evidence and product details so you can have informed conversations with your Idaho healthcare team.

Why OilWell for Fremont County: The Idaho Advantage

We Understand Rural Access Challenges

You’re not in Boise or Coeur d’Alene. You’re in Fremont County, where the nearest specialist might be 90 miles away in Idaho Falls. We’ve built our business around shipping to places like yours—rural Texas counties, remote Montana valleys, isolated communities across America. Our PANDEM1C SEO technology routes your order through the most efficient distribution center for rural delivery.

We Speak Idaho’s Language

We’ve spent six years explaining cannabis to conservative, skeptical audiences. Our evidence-first approach resonates in places where “cannabis” still carries stigma. We don’t use stoner culture language. We talk about research, safety, and self-reliance—values that matter in Fremont County.

We Support Idaho’s Veterans

Idaho has one of the highest per-capita veteran populations in America. Many live in rural Fremont County, dealing with PTSD, chronic pain, and isolation. Our Asshole Peach product is specifically formulated for veterans. Colin’s own PTSD journey informs every product. We ship to VA addresses throughout Idaho.

We Acknowledge Idaho’s Legal Reality

We don’t pretend Idaho is California or Colorado. We’re upfront: our product is federally legal, but Idaho’s laws are restrictive. We provide documentation. We empower you with knowledge. We don’t encourage lawbreaking—we provide a legal pathway that exists within the Farm Bill framework.

We Keep Idaho’s Budget in Mind

At $129.99 for 16,590mg of cannabinoids, our sublingual oil costs $7.84 per 1,000mg of active compounds. Compare to typical CBD products at $40-50 for 1,000mg. Idaho’s rural economy requires value—we deliver it. And if you can’t afford it, our open-source formula lets you make your own.

The Complete Picture: What You’re Getting

Product quality:

• Solvent-free production (no naphtha, no butane)
• Organic MCT oil carrier
• Third-party lab tested (pesticides, heavy metals, residual solvents, microbes)
• Certificates of Analysis available online
• Graduated dropper for precision dosing
• 30-day satisfaction guarantee

Educational value:

• 29 peer-reviewed citations in our knowledge base
• Complete cannabinoid and terpene profiles
• Honest assessment of evidence strength
• No overstated claims
• Transparent about limitations

Community commitment:

• $35,000 in product donated for COVID vaccination (documented by ABC13)
• Proactive ethical action during Delta-8 ban (documented by ABC13)
• Open-source formulas for DIY makers
• Direct phone/email access to our team

Idaho accessibility:

• Ships to every ZIP code in Fremont County
• Discreet packaging for privacy
• Documentation for legal protection
• 2-3 day delivery to rural addresses
• Customer support that understands Idaho’s challenges

Conclusion: Your Path Forward in Fremont County

If you’re in Ashton watching the wheat fields and wondering if this is real—we get it. If you’re in Island Park dealing with chronic pain from years of guiding hunters at high altitude—we’ve helped people like you. If you’re in Driggs supporting a spouse through cancer treatment in Boise while managing the ranch back home—we understand the overwhelm.

We’re not here to sell you hope. We’re here to provide the best possible version of RSO—transparently formulated, legally accessible, honestly described—so you can give it a fair shot and decide if it’s right or wrong for you.

This is what we promise:

• Complete formula transparency (you see every mg)
• Legal Farm Bill compliance (ships to your Idaho door)
• Evidence-based education (no snake oil)
• Patient-controlled potency (you decide psychoactive or not)
• Community support (real people answer our phone)

What we ask of you:

• Consult your healthcare provider (especially if under treatment in Idaho Falls or Boise)
• Understand Idaho’s legal landscape
• Start low, go slow
• Never drive impaired
• Keep products secure from children and pets

Order today:

• Online: OilWellCBD.com
• Phone: (832) 416-2816
• Email: [email protected]

We’ll ship your order within 24 hours. You’ll have it at your Fremont County door in 2-3 days. And you’ll finally have the transparent, evidence-based RSO information that Idaho’s restrictive system has denied you.

We can’t change Idaho’s laws. But we can give you access, education, and control. That’s the OilWell promise—delivered to your doorstep in Ashton, Island Park, St. Anthony, Driggs, and every other corner of Fremont County.

GENERAL KNOWLEDGE: Complete Evidence Evaluation

This section provides the scientific foundation for every claim made above. We include it because you deserve to see our work.

Research Method and Evidence Weighting

We prioritize sources in this order:

1. Human clinical trials
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical literature (when human data is sparse)

The evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and terpenes rely more on reviews, animal work, and pharmacology studies [1]-[29].

NIH Institutional Baseline

• NCCIH states strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite. Most other uses remain early-stage [1].
• FDA has not approved cannabis plant for medical use. Only Epidiolex (CBD) and synthetic THC drugs (dronabinol, nabilone) are approved [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy [1].

Cannabinoid Profiles

CBD [1]-[6]:

• Best evidence: Seizures (Epidiolex FDA-approved)
• Anxiety: 2024 meta-analysis shows significant anxiolytic signal but limited sample [3]
• Pain: Promising but heterogeneous; trial quality limits confidence [4]
• Sleep: Methodologically weak literature [5]
• Safety: Liver enzyme elevation risk; drug interactions [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence limited to specific indications

CBG [7][8]:

• Pharmacology: Precursor to major cannabinoids; CB receptor interactions plus alpha-2 adrenoceptors and 5-HT1A
• Research areas: Neurologic disorders, IBD, antibacterial activity
• Caution: Sold commercially with thin evidence base [7]
• Bottom line: Promising minor cannabinoid, limited clinical validation

Delta-8 THC [9]-[11]:

• Pharmacology: Partial CB1 agonist, less potent than delta-9 [9]
• Evidence: Dominated by animal studies, product chemistry, public health concerns [10]
• Manufacturing: Greater stability than natural plant levels; synthesis concerns [11]
• Bottom line: Psychoactive THC analogue with incomplete safety characterization

THCa [12]:

• Chemistry: Acidic precursor to THC; converts with heat/storage
• Psychoactivity: Non-psychoactive unless decarboxylated
• Research: Anti-inflammatory, neuroprotective, antineoplastic signals (in vitro/rodent only)
• Bottom line: Relevance depends on route, temperature, processing; interpretation must account for conversion to THC

Delta-9 THC [1][13]-[15]:

• Evidence: Chemo nausea, appetite, some pain/MS symptoms [1]
• Pain: High-THC products may provide short-term benefit but increase dizziness, sedation, discontinuation [13]
• Mental health: High-concentration THC linked to psychosis, cannabis use disorder, anxiety/depression [15]
• Bottom line: Therapeutic relevance in some settings, but clearest intoxication/psychiatric safety liabilities

CBN [12][16][17]:

• Reputation vs. reality: Marketed for sleep, human evidence weak [16]
• Research: No clinical trials using validated sleep measures [16]
• Bottom line: Cultural reputation stronger than clinical evidence

CBC [18][19]:

• Pharmacology: Distinct from THC/CBD; antinociceptive, antibacterial signals
• Status: Sold commercially with little clinical safety/efficacy data [18]
• Bottom line: Scientifically credible but clinically immature

Terpene Profiles

Limonene [20]-[22]:

• Multifunctional monoterpene: antioxidant, anti-inflammatory, cardioprotective, gastroprotective
• Caution: Oxidation products are contact allergens [22]
• Bottom line: Active compound but cannabis-specific therapeutic claims need human proof

Myrcene [20][23]:

• Preclinical: anxiolytic, antioxidant, anti-inflammatory, analgesic
• Major gap: Human studies lacking
• Bottom line: Plausible bioactivity, claims ahead of data

Caryophyllene [24]:

• Standout: Selective CB2 agonist (rare terpene-cannabinoid interaction)
• Research: Anti-inflammatory, immunomodulatory, neuroprotective, gastroprotective
• Bottom line: Strongest terpene for cannabinoid significance, but not clinically proven

Pinene [20][25]:

• Brain-health framing: antioxidant, anti-inflammatory, neuroprotective
• Major gap: Well-designed clinical trials lacking
• Bottom line: Deserves attention but cognition claims are hypotheses

Linalool [20][22][25][26]:

• Preclinical: stress, mood, antidepressant mechanisms
• Safety: Oxidized linalool is contact allergen [22]
• Bottom line: Credible bioactive, but clinical proof preliminary

Humulene [20][27]:

• Scoping review: anti-inflammatory, rodent cannabimimetic properties
• Bottom line: Early stage, far from clinical settlement

Terpinolene [20][28]:

• Least characterized: mostly in silico, in vitro, animal studies
• Bottom line: Biologically interesting but especially underdeveloped

Research Limits

• Evidence base is highly uneven—CBD/delta-9 THC strongest; others require caution
• Extract/molecule/synthetic/terpene data are not interchangeable
• Minor cannabinoids are commercially interesting BECAUSE underexplored
• Product quality matters as much as molecule identity [1][10][11][14]
• THCa chemistry changes with storage/heating [12]

Common Overstatements to Avoid

• CBN sleep: Evidence weak, no strong trial base [16][17]
• Myrcene sedation: Human proof limited [23]
• Terpene entourage: Robust clinical proof limited [20][29]
• THCa nonpsychoactive: Only if not heated; conversion matters [12]
• Delta-8 safety: Psychoactive, incomplete safety data [9]-[11]

Practical Takeaways for Our Formula

• Most evidence-developed: CBD and delta-9 THC
• Delta-8: Real activity, less robust safety/efficacy than delta-9
• THCa: Changes with processing—interpretation depends on form
• CBG/CBN/CBC: Clinically immature vs. CBD/THC
• Terpenes: Aromatic/sensory relevance high; therapeutic claims need caution

REFERENCES

[1] National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026.

[2] Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

[3] Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

[4] Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

[5] Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

[6] Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

[7] Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

[8] Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

[9] Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

[10] LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

[11] Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

[12] Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

[13] McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

[14] Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

[15] Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

[16] Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

[17] Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

[18] Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

[19] Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

[20] André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

[21] Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

[22] Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

[23] Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

[24] Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

[25] Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.

[26] Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

[27] Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

[28] Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

[29] Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

RICK SIMPSON SECTION REFERENCES

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

FINAL WORDS FOR FREMONT COUNTY

We know you’re reading this because you need options. Idaho’s restrictive laws have left you searching for answers that should be available through normal medical channels. We’ve spent six years building a product and company that can reach you legally, educate you honestly, and empower you to make informed decisions.

From our founder Colin’s childhood on the dangerous Texas-Mexico border to Bentley’s miracle recovery to seven ABC13 features documenting our commitment to truth over profit—we’ve earned the right to ask for your trust.

Order today. Try it raw. Try it activated. See what works for your body, your condition, your life in Fremont County. And if it doesn’t work for you, we’ll refund your purchase. If you can’t afford it, use our open-source formula to make your own.

That’s the OilWell promise to Idaho—and to you.

Call us: (832) 416-2816
Email: [email protected]
Order: OilWellCBD.com

We ship to Ashton, ID 83420.
We ship to Driggs, ID 83422.
We ship to Island Park, ID 83429.
We ship to St. Anthony, ID 83445.
We ship to every ranch, home, and PO box in Fremont County.

Your access to evidence-based cannabinoid medicine shouldn’t depend on your ZIP code. We’re proving that it doesn’t have to.